Swedish Orphan Biovitrum AB (0MTD)

London
Currency in SEK
321.00
-1.30(-0.40%)
Real-time Data

0MTD Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa15,26115,52918,79022,12326,027
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+7.11%+1.76%+21%+17.74%+17.65%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa3,2253,4844,4134,9525,702
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa12,03612,04514,37717,17120,325
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.13%+0.07%+19.36%+19.43%+18.37%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa78.87%77.56%76.51%77.62%78.09%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa7,5738,2519,85712,50714,492
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+21.52%+8.95%+19.46%+26.88%+15.87%
aa.aaaa.aaaa.aaaa.aaaa.aa1,5941,9872,2522,7433,538
aa.aaaa.aaaa.aaaa.aaaa.aa5,9816,2947,6379,77310,960
aa.aaaa.aaaa.aaaa.aaaa.aa-2-30-32-9-6
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa4,4633,7944,5204,6645,833
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-4.98%-14.99%+19.14%+3.19%+25.06%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa29.24%24.43%24.06%21.08%22.41%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-453-419-453-1,084-1,219
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-91.95%+7.51%-8.11%-139.29%-12.45%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-454-419-458-1,111-1,219
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa1-527-
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-190-17-71-1401
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa3,8203,3583,9963,4404,615
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-2-56--1-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa399-7-312-450-
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,2173,2953,3212,9554,407
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-0.68%-21.86%+0.79%-11.02%+49.14%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa27.63%21.22%17.67%13.36%16.93%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa972616683546528
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa3,2452,6792,6382,4093,879
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa----6
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa3,2452,6792,6382,4093,885
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-1.79%-17.44%-1.53%-8.68%+61.27%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa21.26%17.25%14.04%10.89%14.93%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa3,2452,6792,6382,4093,885
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa11.019.088.927.4711.37
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-2.46%-17.55%-1.71%-16.34%+52.27%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa10.99.038.847.3911.24
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-2.85%-17.16%-2.11%-16.39%+52.1%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa294.66295.05295.6322.66341.73
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa297.64296.8298.45325.97345.56
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa